AUSTIN, TX / ACCESSWIRE / May 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures ...

AUSTIN, TX / ACCESSWIRE / November 29, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a leading minimally invasive medical device company for gastrointestinal and bariatric procedures, ...

AUSTIN, TX / ACCESSWIRE / April 28, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and ...

Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, the ORBERA® Intragastric ...

CONTACT: Apollo Endosurgery, Inc. Stefanie Cavanaugh, 512-279-5100 [email protected] Darrow Associates Investor Relations Matt Kreps, 214-597-8200 [email protected] ...

4. The company’s U.S. revenues decreased 17.8 percent after it stopped selling surgical products in the country. 5. Apollo noted that its total operating expenses decreased $2.3 million year over year ...

Contacts: Apollo Endosurgery, Inc. Stefanie Cavanaugh, 512-279-5100 [email protected] Darrow Associates Investor Relations Matt Kreps, 214-597-8200 [email protected] ...

Apollo Endosurgery, Inc. (APEN) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.11 per share a year ago.

By Reuters June 14, 20178:34 PM UTCUpdated ago June 14 (Reuters) - Apollo Endosurgery Inc: * Apollo Endosurgery inc files for stock shelf offering of ‍ up to $17.3 million - sec filing Source ...

By Reuters February 22, 201810:02 PM UTCUpdated ago Feb 22 (Reuters) - Apollo Endosurgery Inc: ...

Apollo's products are offered in over 75 countries today and include the OverStitch® Endoscopic Suturing System, the OverStitch Sx TM Endoscopic Suturing System, the Orbera® Intragastric Balloon ...